Extracorporeal Membrane Oxygenation (ECMO) Complications - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 7 min read ✅ Medically reviewed
Extracorporeal Membrane Oxygenation (ECMO) Complications – Comprehensive Guide

Overview

Extracorporeal Membrane Oxygenation (ECMO) is a form of advanced life‑support that temporarily takes over the work of the heart and/or lungs. Blood is drained from the patient, oxygenated in an external circuit, and then returned to the circulation. ECMO is used when conventional therapies (ventilators, medication, or surgery) cannot adequately maintain oxygenation or perfusion.

  • Who it affects: Primarily critically‑ill adults and children with severe respiratory or cardiac failure, such as acute respiratory distress syndrome (ARDS), severe pneumonia, myocarditis, or post‑cardiac surgery low‑output states.
  • Prevalence: In the United States, ECMO use rose sharply during the COVID‑19 pandemic. The Extracorporeal Life Support Organization (ELSO) reported > 80,000 ECMO runs worldwide from 2002‑2023, with an annual increase of 12 % in adult cases during 2020‑2022.[ELSO 2023]
  • Purpose of this guide: While ECMO can be lifesaving, it carries a unique set of complications. Understanding the signs, causes, and management strategies helps patients, families, and caregivers navigate the recovery journey.

Symptoms

Complications of ECMO can present with a wide range of symptoms. Not all patients will experience every symptom, and some may be subtle at first.

Bleeding

  • Visible oozing from cannulation sites, nosebleeds, or gastrointestinal bleeding.
  • Hematuria (blood in urine) or melena (black tarry stools).
  • Sudden drop in hemoglobin or platelets on laboratory tests.

Thromboembolic Events

  • Sudden shortness of breath, chest pain, or leg swelling indicating a pulmonary embolism or deep‑vein thrombosis.
  • Neurologic deficits such as weakness, facial droop, or speech changes suggesting stroke.

Infection

  • Fever, chills, or localized redness/purulence at cannulation sites.
  • Elevated white‑blood‑cell count or positive blood cultures.

Hemolysis (destruction of red blood cells)

  • Dark urine, jaundice, or rapid anemia.
  • Elevated plasma free‑hemoglobin and lactate dehydrogenase (LDH) levels.

Neurologic Complications

  • Seizures, altered mental status, or coma.
  • Intracranial hemorrhage (ICH) presenting with headache, vomiting, or focal neurologic signs.

Renal Dysfunction

  • Decreased urine output, swelling, or rising creatinine.
  • Requirement for continuous renal replacement therapy (CRRT).

Mechanical Issues

  • Gear‑related clots or air bubbles in the circuit causing sudden drops in oxygenation.
  • Access cannula malposition leading to limb ischemia (pale, cold, painful extremity).

Cardiovascular Instability

  • Hypotension despite vasoactive support.
  • Arrhythmias or low cardiac output after weaning from ECMO.

Long‑Term Complications

  • Muscle weakness and critical‑illness polyneuropathy.
  • Psychological effects: anxiety, depression, post‑traumatic stress disorder (PTSD).

Causes and Risk Factors

Underlying Disease Process

  • Severe ARDS, viral pneumonia (e.g., COVID‑19, influenza), or septic shock.
  • Cardiac conditions: myocarditis, refractory ventricular arrhythmias, post‑cardiac surgery low output.

Procedure‑Related Factors

  • Large‑bore cannulation (typically 15‑25 Fr) creates a portal for bleeding.
  • Need for systemic anticoagulation (heparin or direct thrombin inhibitors) increases hemorrhage risk.
  • Prolonged circuit time (> 7‑10 days) raises the chance of clot formation and infection.

Patient‑Specific Risk Factors

  • Pre‑existing coagulopathy (e.g., liver disease, thrombocytopenia).
  • Obesity or difficult vascular anatomy, making cannulation more challenging.
  • Renal insufficiency or prior kidney disease.
  • Age extremes: neonates and elderly patients often have higher complication rates.

Institutional Factors

  • Lack of experienced ECMO team or standardized protocols.
  • Inadequate monitoring equipment for circuit pressures or air detection.

Diagnosis

Detecting ECMO‑related complications relies on a combination of clinical vigilance, bedside assessment, and targeted testing.

Bleeding

  • Routine bedside inspection of cannulation sites.
  • Serial complete blood count (CBC) and coagulation profile (PT/INR, aPTT, fibrinogen, platelet count).
  • Imaging: CT angiography for internal bleeding, endoscopy for GI hemorrhage.

Thromboembolism

  • Duplex ultrasonography for DVT.
  • CT pulmonary angiography for PE.
  • Neuro‑imaging (CT/MRI) if stroke suspected.

Infection

  • Blood cultures drawn through the circuit line.
  • Site cultures if there is local drainage.
  • Chest X‑ray or CT for pneumonia or mediastinitis.

Hemolysis

  • Plasma free‑hemoglobin, haptoglobin, LDH, and bilirubin levels.
  • Urinalysis for hemoglobinuria.

Neurologic Complications

  • Daily neurologic exam; use of Sedation‑Holiday protocols when safe.
  • Transcranial Doppler or continuous EEG for detecting seizures.
  • CT/MRI for bleed or ischemia.

Renal Dysfunction

  • Serum creatinine, BUN, electrolytes every 12‑24 h.
  • Urine output monitoring; consider AKI staging (KDIGO criteria).

Mechanical Issues

  • Real‑time pressure monitoring of pre‑ and post‑pump circuits.
  • Bubble detectors and visual inspection for air entry.
  • Echocardiography to assess cannula position and cardiac loading conditions.

Treatment Options

Bleeding Management

  • Adjust anticoagulation: target aPTT 40‑60 seconds or anti‑Xa 0.3‑0.5 IU/mL, depending on protocol.
  • Transfusion of packed red blood cells, platelets, or fresh‑frozen plasma as guided by labs.
  • Local hemostatic measures (pressure dressing, topical agents) and, if necessary, surgical repair.

Thrombosis Prevention & Treatment

  • Maintain therapeutic anticoagulation; monitor anti‑Xa levels for low‑molecular‑weight heparin or direct thrombin inhibitors.
  • Clot in circuit: replace oxygenator or tubing; avoid circuit rupture.
  • Systemic thrombus: thrombolytics (e.g., alteplase) in selected cases, balancing bleed risk.

Infection Control

  • Strict aseptic technique for cannula care; daily dressing changes.
  • Empiric broad‑spectrum antibiotics adjusted per cultures.
  • Consider circuit exchange if persistent bacteremia despite therapy.

Hemolysis Management

  • Optimize pump speed and flow to reduce shear stress.
  • Switch to newer centrifugal pumps if hemolysis persists.
  • Supportive care: transfusions, renal support if AKI develops.

Neurologic Complications

  • Control anticoagulation tightly to avoid ICH.
  • Neurosurgical consultation for evacuation of hemorrhage.
  • Anti‑seizure medication if seizures occur; continuous EEG monitoring.

Renal Support

  • Integrate continuous renal replacement therapy (CRRT) into the ECMO circuit.
  • Fluid balance optimization; avoid nephrotoxic drugs.

Mechanical Problems

  • Immediate circuit troubleshooting: check for air, clots, tubing kinks.
  • Replace oxygenator or tubing set if malfunction persists.
  • Re‑position cannulas under imaging guidance to restore limb perfusion.

Rehabilitation & Lifestyle

  • Early mobilization (passive range of motion, sitting up) as tolerated.
  • Physical therapy after decannulation to address muscle weakness.
  • Psychological counseling and support groups for patients and families.

Living with Extracorporeal Membrane Oxygenation (ECMO) Complications

Even after ECMO is weaned, many patients face ongoing challenges. Below are practical tips for daily management.

  • Medication adherence: Continue anticoagulation (often warfarin or a DOAC) if indicated, with regular INR checks.
  • Wound care: Keep cannulation sites clean; inspect daily for redness or drainage.
  • Monitor for bleeding: Note any new bruising, blood in stool, or coughing up blood and report promptly.
  • Hydration & renal health: Maintain adequate fluid intake unless restricted; monitor weight and urine output.
  • Exercise: Start with light activities (walking, gentle stretching) under physiotherapist guidance to rebuild strength.
  • Vaccinations: Stay up‑to‑date on influenza and pneumococcal vaccines, as respiratory infection risk remains higher.
  • Follow‑up appointments: Cardiology, pulmonary, and nephrology visits are often scheduled every 1‑3 months in the first year.
  • Emotional health: Seek counseling if you experience anxiety, depression, or flashbacks; many centers offer post‑ICU clinics.

Prevention

While not all complications are avoidable, many strategies reduce risk:

  • Experienced ECMO team: Certification programs and simulation training improve procedural safety.
  • Standardized protocols: Anticoagulation algorithms, infection‑prevention bundles, and daily circuit checks.
  • Optimal cannulation technique: Ultrasound‑guided vessel access and use of smaller‑diameter cannulas when feasible.
  • Regular circuit surveillance: Pressure monitoring, visual inspection for clots, and timely oxygenator replacement (usually every 5‑7 days).
  • Early mobilization: Even while on ECMO, limited movement reduces deconditioning and venous stasis.
  • Patient‑specific anticoagulation: Tailor dosing based on platelet function tests, anti‑Xa, or thromboelastography.
  • Nutrition: Early enteral feeding supports gut mucosa and immune function, lowering infection risk.

Complications (If Not Managed Promptly)

Uncontrolled ECMO complications can rapidly become life‑threatening:

  • Massive hemorrhage → hypovolemic shock, organ ischemia, death.
  • Severe thromboembolism → stroke, limb loss, cardiac arrest.
  • Septicemia → multi‑organ failure.
  • Intracranial hemorrhage → permanent neurologic disability.
  • Renal failure → need for long‑term dialysis.
  • Critical‑illness polyneuropathy → prolonged ventilator dependence and reduced quality of life.
  • Psychological sequelae → chronic anxiety, depression, and reduced functional recovery.

When to Seek Emergency Care

Immediate medical attention is required if you notice any of the following while on ECMO or after decannulation:
  • Sudden, heavy bleeding from cannulation sites, gums, or respiratory tract.
  • Severe chest pain, shortness of breath, or sudden leg swelling suggestive of clot.
  • New weakness, numbness, slurred speech, or loss of vision (possible stroke).
  • Severe headache, vomiting, or confusion indicating possible intracranial bleed.
  • Rapid drop in blood pressure despite medication.
  • High fever (> 38.5 °C / 101.3 °F) with chills and red, swollen cannulation site.
  • Dark urine, yellowing of skin or eyes (jaundice), or sudden drop in hemoglobin.
  • Loss of feeling or color change in an arm or leg (limb ischemia).

Call 911 or go to the nearest emergency department right away. Keep your ECMO team’s contact information readily available.

References

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References